Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: a population-based study.

@article{ElSerag2006TreatmentAO,
  title={Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: a population-based study.},
  author={Hashem B. El-Serag and Abby B. Siegel and Jessica A. Davila and Yasser H. Shaib and Mikele Cayton-Woody and Russell B McBride and Katherine A McGlynn},
  journal={Journal of hepatology},
  year={2006},
  volume={44 1},
  pages={158-66}
}
BACKGROUND/AIMS There are several treatment alternatives available for patients diagnosed with hepatocellular carcinoma (HCC). Yet, neither the extent to which potentially curative or palliative therapy is used to treat HCC, nor the determinants of using such therapies are known. Further, it is unclear how effective different modalities are for treating HCC. METHODS We used the linked SEER-Medicare dataset to identify patients diagnosed with HCC between 1992 and 1999. We identified 2963… CONTINUE READING

From This Paper

Topics from this paper.
92 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 92 extracted citations

Similar Papers

Loading similar papers…